Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 42,135 | 6,399 | 1,590 | 7,555 | 8,133 |
| Gross Profit | 42,135 | 6,399 | 1,590 | 7,555 | 8,133 |
| Operating Expenses | 27,041 | 51,867 | 68,568 | 70,209 | 57,187 |
| Operating Income | 15,094 | -45,468 | -66,978 | -62,654 | -49,054 |
| Interest Expense | 0 | 0 | 0 | 268 | 198 |
| Other Income | 45 | 323 | 2,734 | 6,532 | 4,204 |
| Pre-tax Income | 15,139 | -45,145 | -64,244 | -56,390 | -45,048 |
| Net Income Continuous | 15,139 | -45,145 | -64,244 | -56,390 | -45,048 |
| Net Income | $15,139 | $-45,145 | $-64,244 | $-56,390 | $-45,048 |
| EPS Basic Total Ops | 0.39 | -1.20 | -1.73 | -1.60 | -1.61 |
| EPS Basic Continuous Ops | 0.39 | -1.20 | -1.73 | -1.60 | -1.61 |
| EPS Diluted Total Ops | 0.39 | -1.20 | -1.73 | -1.60 | -1.61 |
| EPS Diluted Continuous Ops | 0.39 | -1.20 | -1.73 | -1.60 | -1.61 |
| EBITDA(a) | $15,584 | $-44,097 | $-65,024 | $-61,886 | $-49,200 |